Mark Fluchel

1.9k total citations
47 papers, 1.0k citations indexed

About

Mark Fluchel is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Speech and Hearing. According to data from OpenAlex, Mark Fluchel has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pediatrics, Perinatology and Child Health, 22 papers in Public Health, Environmental and Occupational Health and 12 papers in Speech and Hearing. Recurrent topics in Mark Fluchel's work include Childhood Cancer Survivors' Quality of Life (27 papers), Acute Lymphoblastic Leukemia research (19 papers) and Adolescent and Pediatric Healthcare (12 papers). Mark Fluchel is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (27 papers), Acute Lymphoblastic Leukemia research (19 papers) and Adolescent and Pediatric Healthcare (12 papers). Mark Fluchel collaborates with scholars based in United States, Canada and Uruguay. Mark Fluchel's co-authors include Anne C. Kirchhoff, Jennifer Wright, Echo L. Warner, Gina Nam, Anita Y. Kinney, Courtney R. Lyles, Wendy M. Leisenring, Sapna Kaul, Carol Sweeney and Julia Bodson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Fluchel

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Fluchel United States 17 610 386 221 204 153 47 1.0k
Jacqueline Casillas United States 17 872 1.4× 688 1.8× 300 1.4× 239 1.2× 361 2.4× 43 1.4k
Rohit P. Ojha United States 20 507 0.8× 289 0.7× 87 0.4× 160 0.8× 231 1.5× 71 1.1k
David S. Dickens United States 14 531 0.9× 402 1.0× 281 1.3× 57 0.3× 130 0.8× 41 1.0k
J. Rautonen Finland 18 428 0.7× 195 0.5× 139 0.6× 175 0.9× 105 0.7× 29 988
Amanda Shaw Canada 18 792 1.3× 496 1.3× 184 0.8× 380 1.9× 297 1.9× 37 1.4k
Lindsey Hageman United States 13 739 1.2× 694 1.8× 311 1.4× 54 0.3× 216 1.4× 75 1.2k
Paola Friedrich United States 13 792 1.3× 636 1.6× 90 0.4× 46 0.2× 333 2.2× 44 1.2k
Leslie S. Kersun United States 19 510 0.8× 300 0.8× 96 0.4× 193 0.9× 171 1.1× 48 1.1k
Pinki Prasad United States 12 408 0.7× 267 0.7× 93 0.4× 207 1.0× 117 0.8× 24 639
Jodi Skiles United States 18 418 0.7× 350 0.9× 56 0.3× 54 0.3× 347 2.3× 53 1.1k

Countries citing papers authored by Mark Fluchel

Since Specialization
Citations

This map shows the geographic impact of Mark Fluchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fluchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fluchel more than expected).

Fields of papers citing papers by Mark Fluchel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Fluchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fluchel. The network helps show where Mark Fluchel may publish in the future.

Co-authorship network of co-authors of Mark Fluchel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Fluchel. A scholar is included among the top collaborators of Mark Fluchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Fluchel. Mark Fluchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Dominic, et al.. (2025). Palliative and End-of-Life Disparities for Pediatric Hispanic, Spanish-preferring Patients With Cancer. Journal of Pediatric Hematology/Oncology. 47(4). 197–203.
2.
Bussel, James B., et al.. (2024). Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome. Pediatric Blood & Cancer. 71(10). e31239–e31239. 2 indexed citations
3.
Maughan, Benjamin L., et al.. (2024). Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report. Urology Case Reports. 56. 102799–102799.
4.
Eslin, Don, Peter E. Zage, Genevieve Bergendahl, et al.. (2023). A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma. International Journal of Cancer. 153(5). 1026–1034. 5 indexed citations
5.
El‐Mallawany, Nader Kim, Sarah Alexander, Mark Fluchel, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphoma. Pediatric Blood & Cancer. 70(S6). e30565–e30565. 8 indexed citations
6.
7.
Waters, Austin R., et al.. (2021). A qualitative inquiry of communication based barriers to the diagnosis of pediatric cancer: Perceptions of primarily Spanish-speaking caregivers. Patient Education and Counseling. 105(6). 1503–1509. 9 indexed citations
8.
Kirchhoff, Anne C., Echo L. Warner, Heydon K. Kaddas, et al.. (2019). HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Human Vaccines & Immunotherapeutics. 15(7-8). 1767–1775. 10 indexed citations
9.
Picarsic, Jennifer, Theodore J. Pysher, Holly Zhou, et al.. (2019). BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathologica Communications. 7(1). 168–168. 36 indexed citations
10.
11.
Nam, Gina, et al.. (2016). Understanding psychological distress among pediatric cancer caregivers. Supportive Care in Cancer. 24(7). 3147–3155. 24 indexed citations
12.
Nam, Gina, Sapna Kaul, Yelena P. Wu, et al.. (2015). A meta-analysis of body mass index of adolescent and adult survivors of pediatric acute lymphoblastic leukemia. Journal of Cancer Survivorship. 9(3). 412–421. 16 indexed citations
13.
Smock, Kristi J., Joshua D. Schiffman, Mark Fluchel, et al.. (2015). Pegasparaginase treatment alters thrombin generation by modulating the protein C and S system in acute lymphoblastic leukaemia/lymphoma. Blood Coagulation & Fibrinolysis. 26(7). 840–843. 7 indexed citations
14.
Kirchhoff, Anne C., Roberto E. Montenegro, Echo L. Warner, et al.. (2014). Childhood cancer survivors’ primary care and follow-up experiences. Supportive Care in Cancer. 22(6). 1629–1635. 25 indexed citations
15.
Botto, Lorenzo D., Timothy J. Flood, Julian Little, et al.. (2013). Cancer Risk in Children and Adolescents with Birth Defects: A Population-Based Cohort Study. PLoS ONE. 8(7). e69077–e69077. 62 indexed citations
16.
Kirchhoff, Anne C., Courtney R. Lyles, Mark Fluchel, Jennifer Wright, & Wendy M. Leisenring. (2012). Limitations in health care access and utilization among long‐term survivors of adolescent and young adult cancer. Cancer. 118(23). 5964–5972. 119 indexed citations
17.
Bennett, Tellen D., Mark Fluchel, Aimee O. Hersh, et al.. (2012). Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis & Rheumatism. 64(12). 4135–4142. 53 indexed citations
18.
Lestini, Brian, Kelly C. Goldsmith, Mark Fluchel, et al.. (2009). Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists. Cancer Biology & Therapy. 8(16). 1587–1595. 76 indexed citations
19.
Fluchel, Mark, et al.. (2007). Self and proxy‐reported health status and health‐related quality of life in survivors of childhood cancer in Uruguay. Pediatric Blood & Cancer. 50(4). 838–843. 31 indexed citations
20.
Castillo, Luis, et al.. (2001). Childhood cancer in Uruguay: 1992–1994. Incidence and mortality. Medical and Pediatric Oncology. 37(4). 400–404. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline Casillas Breakdown of academic impact, for papers by Rohit P. Ojha Breakdown of academic impact, for papers by David S. Dickens Breakdown of academic impact, for papers by J. Rautonen Breakdown of academic impact, for papers by Amanda Shaw Breakdown of academic impact, for papers by Lindsey Hageman Breakdown of academic impact, for papers by Paola Friedrich Breakdown of academic impact, for papers by Leslie S. Kersun Breakdown of academic impact, for papers by Pinki Prasad Breakdown of academic impact, for papers by Jodi Skiles
Rankless by CCL
2026